Local IFNγ signaling contributes to the regenerative decline of aged alveolar progenitor cells

This study demonstrates that chronic local IFNγ signaling from CD8+ T cells in tertiary lymphoid structures actively represses the regenerative capacity of aged alveolar type II cells, a decline that can be partially reversed by neutralizing this inflammatory pathway.

The Gist

The Big Picture: Why Do Lungs Get "Tired" as We Age?

Imagine your lungs are a bustling city. The Alveolar Type II (AT2) cells are the city's master builders and repair crews. Their job is to fix damaged air sacs and build new ones to keep your breathing smooth.

As we get older, these repair crews start to slow down. They don't fix things as fast, and the city (your lungs) starts to crumble, leading to diseases like COPD or just general breathlessness. Scientists have long wondered: Is it because the builders themselves are getting old and tired, or is it because the environment around them is toxic?

This paper answers that question: It's the environment. Specifically, a constant, low-level "alarm" signal is keeping the builders from doing their job.

---

The Analogy: The "False Alarm" Neighborhood

1. The Builders (AT2 Cells)

Think of the AT2 cells as skilled construction workers. In a young, healthy lung, they are quiet, resting, and ready to spring into action when a storm hits (like a virus or injury). They know exactly when to start building and when to stop.

2. The Neighborhood Watch (T-Cells)

In an aging lung, the neighborhood watch (immune cells called CD8+ T-cells) gets a little paranoid. They start hanging out in specific spots called Tertiary Lymphoid Structures (TLS). Think of these as little "security checkpoints" or "guard towers" that form in the lung tissue as we age.

3. The False Alarm (IFNγ)

These guard towers start shouting a constant, loud warning signal called Interferon-gamma (IFNγ).

• In a young lung: This signal is like a fire alarm that only goes off when there is a real fire (an infection).
• In an old lung: The alarm is stuck in the "ON" position. It's blaring 24/7, even though there is no fire.

4. The Confused Builders

The construction workers (AT2 cells) hear this constant alarm. Because the alarm says "DANGER! INVADERS!" the workers get confused. They think, "Oh no, we are under attack! We need to stop building and start fighting!"

So, instead of repairing the lung, they start changing their uniforms. They put on "combat gear" (increasing MHC-I proteins, which are like flags saying "Look at me, I'm a target!") and stop working. They become stressed, tired, and lose their ability to regenerate the lung tissue.

---

What the Scientists Did (The Experiments)

The researchers wanted to prove that this "False Alarm" was the real culprit. They ran several tests:

• The "Silence the Alarm" Test: They took old mice and gave them a special medicine that blocked the IFNγ signal (like putting a mute button on the fire alarm).
  • Result: The construction workers stopped panicking. They took off their combat gear and went back to building. The old lungs started regenerating again!
• The "Fake Alarm" Test: They took young, healthy mice and forced the alarm to blare constantly.
  • Result: The young workers got confused, stopped building, and acted just like the old, tired workers.
• The "No Guards" Test: They looked at mice that couldn't make the guard towers (T-cells).
  • Result: Without the guards, there was no alarm, and the old workers stayed calm and kept working.

The "Why" Behind the Alarm

The paper also explains why the guards are so paranoid. It turns out the guards are looking for "bad guys" (cancer or viruses) by checking the workers' ID badges.

• The aging workers accidentally show more "ID badges" (MHC-I proteins) on their surface.
• The guards see these badges and think, "Hey, that worker looks suspicious! Let's yell at them!"
• This creates a vicious cycle: The workers get yelled at, show more badges to prove they are innocent, and the guards yell even louder.

The Takeaway: A New Hope for Aging Lungs

The most exciting part of this discovery is that this decline isn't permanent.

For a long time, we thought aging lungs were just "worn out" and couldn't be fixed. But this paper shows that the problem is a communication error. The workers are actually still capable of doing their job; they just need the neighborhood to stop screaming at them.

The Solution?
If we can develop drugs that:

1. Turn down the volume on the IFNγ alarm (neutralize the signal).
2. Or stop the guards from forming those security checkpoints (TLS).

...we might be able to help old lungs regenerate themselves, even in very elderly people. It's like giving the construction crew a quiet, safe environment so they can finally get back to work and rebuild the city.

Summary in One Sentence

Aging lungs don't fail because the repair cells are broken; they fail because a constant, false alarm from immune cells tricks them into stopping work, and turning off that alarm can bring the repair crew back to life.

Technical Summary

1. Problem Statement

The aging lung is highly susceptible to chronic diseases (e.g., COPD, emphysema) due to a decline in the regenerative capacity of alveolar type II (AT2) cells, the facultative progenitors responsible for maintaining the gas-exchange surface. While cell-intrinsic metabolic defects (e.g., iron homeostasis, glycolysis) in aged AT2 cells are known, the influence of the aged lung microenvironment remains poorly understood. Specifically, the role of chronic, low-grade inflammation ("inflammaging") and specific interferon signaling pathways in driving AT2 dysfunction in homeostatic (non-injured) aged lungs has not been fully elucidated.

2. Methodology

The study employed a multi-modal approach combining in vivo mouse models, ex vivo organoid assays, and advanced omics technologies:

• Animal Models:
  • Aging Models: Young (2–4 months) vs. Old (18–24 months) C57BL/6J mice.
  • Genetic Knockouts:
    • IFNγR1 Conditional KO: AT2-specific deletion of the IFNγ receptor (using Sftpc-CreER x IfngR1-flox).
    • Immunoproteasome Triple KO (IP KO): Mice lacking catalytic subunits Psmb8, Psmb9, and Psmb10, which impairs MHC-I antigen presentation and CD8+ T cell development.
    • Foxn1 KO: Nude mice lacking T cells to assess T-cell dependency.
  • Interventions: Neutralization of IFNγ via intraperitoneal/intratracheal antibody treatment; recombinant IFNγ (rIFNγ) treatment in organoid cultures.
• Omics and Sequencing:
  • Bulk RNA-seq: FACS-isolated AT2 cells from young vs. old lungs.
  • Single-cell RNA-seq (scRNA-seq): Re-analysis of existing datasets and new analysis of lymphocyte compartments.
  • Single-nucleus Multi-omics (snMultiomic-seq): Joint RNA and ATAC sequencing to distinguish transcriptional changes from chromatin accessibility changes.
  • Human Data: Analysis of the Human Lung Cell Atlas (HLCA) to validate findings in aged human AT2 cells.
• Functional Assays:
  • Alveolar Organoids: Feeder-free and stroma-supported cultures to measure Organoid Forming Efficiency (OFE) and differentiation potential (AT2 to AT1).
  • Flow Cytometry: Quantification of surface MHC-I, intracellular IFNγ in lung-resident lymphocytes (distinguishing resident vs. circulating cells via anti-CD45 retro-orbital injection).
  • Spatial Analysis: RNAscope (RNA in situ hybridization) and Multiplex Immunofluorescence (mIF) to localize IFNγ+ cells and Tertiary Lymphoid Structures (TLS).

3. Key Contributions & Results

A. Aged AT2 Cells Exhibit a Conserved IFNγ-Response Signature

• Transcriptional Changes: Bulk RNA-seq and scRNA-seq revealed that aged AT2 cells (both murine and human) consistently upregulate genes associated with MHC-I antigen presentation and the immunoproteasome (e.g., B2m, H2-K1, Psmb8, Psmb9, Nlrc5).
• Microenvironment Dependence: When aged AT2 cells were cultured ex vivo in organoids (removing the aged lung microenvironment), the upregulation of IFNγ-responsive genes (MHC-I/immunoproteasome) was lost, while intrinsic aging markers (e.g., Nrn1) persisted. This indicates the IFNγ state is driven by the local microenvironment, not just cell-intrinsic aging.
• Chromatin State: snATAC-seq showed that chromatin accessibility at MHC-I loci did not change with age, suggesting the upregulation is driven by extrinsic signaling rather than intrinsic epigenetic remodeling.

B. Local IFNγ Signaling Represses Regeneration

• Functional Impact: Treatment of young and old organoids with rIFNγ significantly reduced organoid formation efficiency (OFE), demonstrating that IFNγ directly represses AT2 self-renewal.
• Receptor Specificity: AT2 cells from IFNγR1 conditional KO mice were resistant to the repressive effects of rIFNγ, confirming the effect is mediated through the AT2 cell's IFNγ receptor.
• Therapeutic Rescue:
  • Antibody Neutralization: Treating aged mice with anti-IFNγ antibodies for one week reduced surface MHC-I on AT2 cells and significantly rescued organoid-forming efficiency compared to IgG controls.
  • Immunoproteasome KO: Aged IP KO mice (which have defective antigen presentation and reduced CD8+ T cell accumulation) showed partially rescued AT2 regeneration and reduced expression of IFNγ-responsive genes compared to wild-type aged mice.

C. Cellular Source: Tertiary Lymphoid Structures (TLS)

• Cellular Origin: scRNA-seq and flow cytometry identified that IFNγ+ CD8+ T cells (specifically GZMK+ subsets) and NK cells accumulate in aged lungs.
• Spatial Localization: These IFNγ+ T cells are not randomly distributed but are concentrated within Tertiary Lymphoid Structures (TLS)—perivascular/peribronchiolar aggregates found in healthy aged lungs.
• Mechanism: A feedforward loop is proposed: Immunoproteasome function in epithelial cells facilitates antigen presentation $\rightarrow$ accumulation of CD8+ T cells in TLS $\rightarrow$ local IFNγ release $\rightarrow$ repression of AT2 regeneration.

4. Significance and Implications

• Paradigm Shift: The study challenges the view that chronic inflammation in aging is merely a byproduct of tissue damage. Instead, it establishes local IFNγ signaling as a direct, active cause of age-related regenerative decline in the lung.
• Reversibility: The regenerative decline of aged AT2 cells is partially reversible. Halting the chronic inflammatory loop (via IFNγ neutralization or disrupting antigen presentation) restores progenitor function, suggesting that "aging" of stem cells is not entirely fixed.
• Therapeutic Potential:
  • Immunoproteasome Inhibitors: Since IP KO mice showed rescue, existing clinical immunoproteasome inhibitors (currently used for cancer/autoimmunity) could be repurposed for age-related lung diseases.
  • Targeted Immunomodulation: Strategies to deplete IFNγ-releasing T cells or block IFNγ signaling specifically in the lung niche could improve lung health in the elderly without necessarily compromising systemic immunity.
• Broader Context: This work links the formation of TLS (often associated with autoimmunity or cancer) to the physiological decline of lung repair in healthy aging, highlighting a complex interplay between the immune system and tissue regeneration.

Conclusion

Jensen et al. demonstrate that the aged lung microenvironment creates a chronic, local IFNγ-rich niche driven by CD8+ T cells in TLS. This signaling directly reprograms AT2 progenitor cells into a non-regenerative, MHC-I-high state. Disrupting this axis restores regenerative capacity, offering a promising therapeutic avenue for age-related respiratory failure and chronic lung diseases.